News | Coronavirus (COVID-19) | June 18, 2020

AI-powered Diagnostic Solution From QuEST Global to Accelerate COVID-19 Screening

QuEST Global, a global product engineering and lifecycle services company, announced that it has developed a robust artificial intelligence (AI)-powered solution that will enable healthcare professionals to accelerate the screening of COVID-19 patients with pneumonia symptoms.

Getty Images

June 18, 2020 — QuEST Global, a global product engineering and lifecycle services company, announced that it has developed a robust artificial intelligence (AI)-powered solution that will enable healthcare professionals to accelerate the screening of COVID-19 patients with pneumonia symptoms. Using advanced deep learning models, the AI-powered diagnostic solution can sort and identify chest X-rays of patients with COVID-19. With an accuracy of more than 95%, the solution can be deployed on the cloud as a service, making it easily accessible on edge for healthcare professionals and end-users. The solution is backed by Microsoft Azure Machine Learning, which helps accelerate the development and deployment on machine learning models in a highly secure and trusted fashion.

The Medical Devices engineering team at QuEST developed this technology demonstrator using chest X-rays of healthy individuals, patients with symptoms of pneumonia and COVID-19. These X-rays were used to train and build a deep neural network model that could discriminate the radiological patterns of pneumonia related to COVID-19 and highlight the suspicious ones, thus leading to a faster screening of the disease.

Elaborating further on QuEST's AI solution, Krish Kupathil, Global Head, Hi-Tech and Digital, QuEST Global, said, "As the pandemic continues to rage, our focus has been to deliver a solution that can support the healthcare professionals effectively. Since the fight against COVID-19 is all about faster screening and immediate isolation of maximum number of people, we aim to accelerate the screening time as much as possible. The AI-based solution will make radiography examinations much faster by leveraging modern image diagnostic systems. As we continue to add more features, we aim to reduce the screening time to less than a minute."

Michael Kuptz, General Manager – Americas IoT & Mixed Reality Sales, Microsoft, said, "In these unprecedented times, saving human lives is the ultimate goal, and technology can help. Microsoft's collaborations with product engineering leaders like QuEST can go a long way to driving a more positive outcome. For example, QuEST's AI-driven diagnostic solution, built on Microsoft Azure, empowers healthcare personnel in the fight against COVID-19 by reducing screening time, thereby enabling more testing capacity."

Over the years, QuEST has been working as a trusted thinking partner with the world's most recognized companies in the medical devices industry. The company is committed to enabling its customers Create The Frontier by enhancing healthcare experience to improve the lives of millions of people around the world. With its expertise in new-age technologies like deep learning, AI, IoT and machine learning, the company has been developing comprehensive engineering solutions by using Azure IoT and Azure AI solutions. These solutions have been helping OEMs, and tier-one suppliers seamlessly take a giant leap in their digital transformation journey and make products safer and more reliable.

For more information: www.quest-global.com

Related Content

A lung CT of a COVID-19 patient, showing ground-glass opacities in the lung from COVID pneumonia. Image courtesy of John Kim.

A lung CT of a COVID-19 patient, showing ground-glass opacities in the lung from COVID pneumonia. Image courtesy of John Kim.

News | Coronavirus (COVID-19) | July 09, 2020
July 9, 2020 — With increased lung CT exam paradigms being used in the current...
World's largest radiation oncology meeting will offer full conference on interactive platform October 25-28, 2020
News | ASTRO | July 09, 2020
July 9, 2020 — Registration opens today for the American Society for Radiation Oncology's (...

Image courtesy of GE Healthcare

Feature | Mobile C-Arms | July 08, 2020 | By Melinda Taschetta-Millane
Moblie C-arms have seen several advances over the past de
At the American Association of Physicists in Medicine (AAPM) 2019 meeting, new artificial intelligence (AI) software to assist with radiotherapy treatment planning systems was highlighted. The goal of the AI-based systems is to save staff time, while still allowing clinicians to do the final patient review. 
Feature | Treatment Planning | July 08, 2020 | By Melinda Taschetta-Millane
At the American Association of Physicists in Medicine (AAPM) 201
 Many patients with severe coronavirus disease 2019 (COVID-19) remain unresponsive after surviving critical illness. Investigators led by a team at Massachusetts General Hospital (MGH) now describe a patient with severe COVID-19 who, despite prolonged unresponsiveness and structural brain abnormalities, demonstrated functionally intact brain connections and weeks later he recovered the ability to follow commands

Getty Images

News | Coronavirus (COVID-19) | July 08, 2020
July 8, 2020 — Many patients with severe coronavirus disease 2019 (...
Several drivers will contribute to the growth of the teleradiology market in terms of penetration, revenue and read volumes over the next five years

Getty Images

Feature | Teleradiology | July 08, 2020 | By Arun Gill
Last year was a record year for the global...
Fujifilm’s Sonosite SII POC ultrasound system helps to keep crowded areas clearer with a small ultrasound footprint.

Fujifilm’s Sonosite SII POC ultrasound system helps to keep crowded areas clearer with a small ultrasound footprint.

Feature | Ultrasound Imaging | July 07, 2020 | By Joan Toth
With the miniaturization of technology, improved ease of use, lower system cost, increased portability and greater ac